Advertisement

Klinische Wochenschrift

, Volume 67, Issue 22, pp 1117–1125 | Cite as

Neuere Aspekte zur Pathogenese endokriner Autoimmunerkrankungen des Menschen: Welche Rolle spielt die Expression von HLA Klasse-II-Molekülen durch die endokrine Zielzelle?

  • U. Deuß
  • M. Buscema
  • G. F. Bottazzo
  • W. Winkelmann
Übersicht

Abkürzungen

MHC

Haupthistokompatibilitätskomplex

HLA

MHC des Menschen

APC

antigenpräsentierende Zelle

PHA

Phythämagglutinin

IFN

Interferon

IL

Interleukin

TNF

Tumor Necrosis Faktor

IDDM

Diabetes mellitus Typ I

RR

relatives Risiko

Current aspects in the pathogenesis of endocrine autoimmunity in man: The inappropriate expression of HLA class II molecules

Summary

The inappropriate expression of HLA Class II molecules by the target cells of endocrine autoimmune diseases is a recent observation that has been intensively studied in thyroid autoimmunity and type I diabetes mellitus. In vitro studies have shown that interferon-γ can induce Class II expression, either alone, as in thyrocytes, or in combination with other mediators like tumour necrosis factor or lymphotoxin, as in islet cells, pointing to possible mechanisms operating in vivo. Endocrine cells expressing Class II molecules are able to present their autoantigens to helper T cells, thus possibly inducing the autoimmune process. However, until now it is still unclear if the expression of Class II molecules by the target cells is the primary immune phenomenon, which might possibly be triggered by a latent viral infection of the endocrine cell. Alternatively, it might be a secondary response in an ongoing autoimmune process. Particularly data obtained in the diabetic pancreas favour the first possibility, but only progress in our understanding of the role of HLA antigens in immunoregulation will make it possible to interpret the phenomenon properly.

Key words

Autoimmune diseases Diabetes mellitus type I Autoimmune thyroiditis HLA-D antigens Immune response 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Acuto O, Reinherz EL (1985) The human T cell receptor: structure and function. N Engl J Med 312:1100–1111Google Scholar
  2. 2.
    Aichinger G, Fill H, Wick G (1985) In situ immune complexes: lymphocyte subpopulations and HLA-DR positive epithelial cells in Hashimoto thyroiditis. Lab Invest 52:132–140Google Scholar
  3. 3.
    Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF (1984) Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet II:1009–1013Google Scholar
  4. 4.
    Ballardini G, Bianchi FB, Mirakian R, Pisi E, Bottazzo GF (1987) HLA-A, B, C and HLA-D/DR on liver biopsies from patients with chronic liver disease. Clin Exp Immunol 70:35–46Google Scholar
  5. 5.
    Belfiore A, Pujol-Borrell R, Mauerhoff T, Mirakian R, Bottazzo GF (1986) Effect of SV-40 transformation on HLA expression by thyroid follicular cells: a rise of a population of DR positive thyrocytes. Annales d'Endocrinologie 47:17Google Scholar
  6. 6.
    Belfiore A, Bottazzo GF (1987) Epidemiology of autoallergic human thyroiditis. Monogr Allergy 21:215–245Google Scholar
  7. 7.
    Bjorkman PJ, Saper NA, Samraoui B, Bennett B, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T cell recognition regions of Class I histocompatibility antigens. Nature 329:512–518Google Scholar
  8. 8.
    Borysiewicz LK, Sissons JPG (1986) Immune responses to virus-infected cells. Clinics in Immunology and Allergy 6:159–188Google Scholar
  9. 9.
    Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Hypothesis: role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet II:1115–1119Google Scholar
  10. 10.
    Bottazzo GF, Dean BM, McNally JM, Hackay EH, Swift PGF, Gamble DR (1985) In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353–360Google Scholar
  11. 11.
    Bottazzo GF, Pujol-Borrell R, Gale E (1986) Autoimmunity and diabetes: progress, consolidation and controversy. In: Alberti KGMM, Krall LP (eds) The Diabetes Annual/3. Elsevier Science Publishers, Amsterdam, pp 13–29Google Scholar
  12. 12.
    Bovo P, Mirakian R, Merigo F, Angelini G, Pujol-Borrell R, Cavallini G, Bottazzo GF, Scuro LA (1985) Chronic alcoholic pancreatitis: is autoimmunity involved? Digestive Diseases and Science 30:964Google Scholar
  13. 13.
    Bovo P, Mirakian R, Merigo F, Angelini G, Cavallini G, Rizzini P, Bottazzo GF, Scuro LA (1987) HLA molecule expression on chronic pancreatitis specimens: is there a role for autoimmunity? A preliminary study. Pancreas 2:350–356Google Scholar
  14. 14.
    Burman P, Tötterman TH, Öberg K, Karlsson FA (1986) Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocr Metab 63:1086–1090Google Scholar
  15. 15.
    Buscema M, Todd I, Deuß U, Hammond L, Pujol-Borrell R, Bottazzo GF (1989) Influence of tumor necrosis factor-α on the modulation by interferon-γ of HLA class II in human thyroid cells and its effect on interferon-γ binding. J Clin Endocr Metab (in press)Google Scholar
  16. 16.
    Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190:147–152Google Scholar
  17. 17.
    Davies TF (1985) Cocultures of human thyroid monolayer cells and autologous T cells: impact of HLA Class II antigen expression. J Clin Endocr Metab 61:418–422Google Scholar
  18. 18.
    Deuß U, Buscema M, Mauerhoff T, Mirakian R (1987) IFN-gamma receptor studies in relation to different sensitivity to Class II expression on normal and SV-40 transfected human thyrocytes. Annales d'Endocrinologie 48:120Google Scholar
  19. 19.
    De Vries RR, Van Rood JJ (1985) Immunobiology of HLA class-I and class-II molecules. Introduction. Prog Allergy 36:1–9Google Scholar
  20. 20.
    Dorf ME (1981) The Role of the Major Histocompatibility Complex in Immunobiology. Chichester: Wiley, New YorkGoogle Scholar
  21. 21.
    Eisenbarth GS (1985) Immunogenetics of endocrine disorders. Immunol Today 6:345–347Google Scholar
  22. 22.
    Foulis AK, Farquharson MA (1986) Aberrant expression of HLA-DR antigens by insulin containing beta cells in recent onset type I (insulin-dependent) diabetes mellitus. Diabetes 35:1215–1226Google Scholar
  23. 23.
    Foulis AK, Farquharson A, Hardman R (1987) Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type I (insulin-dependent) diabetes mellitus. Diabetologia 30:333–343Google Scholar
  24. 24.
    Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet II:1363–1365Google Scholar
  25. 25.
    Guerin V, Hammond LJ, Todd I, Bottazzo GF (1988) Suppression of HLA Class II expression on thyrocytes by interferon-alpha-1. British Society for Immunology (abstract) 40Google Scholar
  26. 26.
    Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet II:1111–1115Google Scholar
  27. 27.
    Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT (1986) Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 232:1145–1147Google Scholar
  28. 28.
    Jalkanen S, Steere AC, Fox RI, Butcher EC (1986) A distinct endothelial cell “recognition” system that controls lymphocyte traffic into inflamed synovium. Science 233:556–558Google Scholar
  29. 29.
    Jansson R, Karlsson A, Forsum U (1984) Intrathryoidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goiter. Clin Exp Immunol 58:264–272Google Scholar
  30. 30.
    Kallenberg CGM, Schilizzi BM, Beaumont F, Popperria S, Deleij L, The TE (1987) Expression of Class II MHC antigens on alveolar epithelium in fiborising alveolitis. Clin Exp Immunol 67:182–190Google Scholar
  31. 31.
    Lindahl G, Hedfors E, Klareskog EL, Forsum U (1985) Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 61:475–486Google Scholar
  32. 32.
    Lo D, Burkly LC, Widera G, Cowing C, Flavell RA, Palmiter RD, Brinster RL (1988) Diabetes and tolerance in transgenic mice expressing Class II MHC molecules in pancreatic beta cells. Cell 53:159–168Google Scholar
  33. 33.
    Londei M, Lamb JR, Bottazzo GF, Feldmann M (1984) Epithelial cells expressing aberrant MHC Class II determinants can present antigen to cloned human T cells. Nature 312:639–641Google Scholar
  34. 34.
    Londei M, Bottazzo GF, Feldmann M (1985) Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 228:85–89Google Scholar
  35. 35.
    Lu CY, Changelian PS, Unanue ER (1984) Alpha-fetoprotein inhibits macrophage expression of Ia antigens. J Immunol 132:1722–1727Google Scholar
  36. 36.
    Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R (1988) Occurrence of thyrocyte Class II expression in a wide variety of thyroid diseases: relationship with lymphocyte infiltration and thyroid autoantibodies. J Clin Endocr Metab 66:367–375Google Scholar
  37. 37.
    Messenger AG, Bleehen SS, Slater DN, Rooney N (1984) Expression of HLA-DR in hair follicles in alopecia areata. Lancet II:287–288Google Scholar
  38. 38.
    Mirakian R, Richardson A, Milla PJ, Unsworth J, Walker-Smith J, Savage M, Bottazzo GF (1986) Idiopathic protracted diarrhoea of infancy: an autoimmune variant. Br Med J 293:1132–1136Google Scholar
  39. 39.
    Müller U, Jongeneel CV, Nedospasov SA, Fischer Lindahl K, Steinmetz M (1987) Tumor necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex. Nature 325:265–267Google Scholar
  40. 40.
    Natali PG, De Martino C, Quaranta V, Nicotra MR, Frezza F, Pellegrino MA, Ferrone S (1981) Expression of Ia like antigens in normal human non-lymphoid tissues. Transplantation 31:75–78Google Scholar
  41. 41.
    Nixon DF, Ting JP, Frelinger A (1982) Ia antigen on non-lymphoid tissues: their origins and functions. Immunol Today 3:339–342Google Scholar
  42. 42.
    Owerbach D, Rich C, Carnegie S, Tanga K (1987) Molecular biology of the HLA system in insulin-dependent diabetes mellitus. In: DeFronzo RA, Skyler JS (eds) Diabetes. John Wiley and Sons, New York, Metab Rev 3:819–834Google Scholar
  43. 43.
    Pujol-Borrell R, Hanafusa T, Chiovato L, Bottazzo GF (1983) Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature 304:71–73Google Scholar
  44. 44.
    Pujol-Borrell R, Todd I, Londei M, Foulis A, Feldmann M, Bottazzo GF (1986a) Inappropriate MHC class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type 1 diabetes. J Mol Biol Med 6:159–165Google Scholar
  45. 45.
    Pujol-Borrell R, Todd I, Doshi M, Gray D, Feldmann M, Bottazzo GF (1986b) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 65:128–139Google Scholar
  46. 46.
    Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf G, Feldmann M (1987) HLA Class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 326:304–306Google Scholar
  47. 47.
    Rémy JJ, Salamero J, Michel-Bechet M, Charreire J (1987) Experimental autoimmune thyroiditis induced by recombinant interferon-γ. Immunol Today 8:73Google Scholar
  48. 48.
    Rotter JI, Vadheim CM, Raffel LJ, Romoin DL, Riley WJ, MacLaren NK (1986) Genetic etiologies of diabetes. In: Laron Z, Karp M (eds) Pediatric Adolescent Endocrinology. Karger, Basel 15:1–11Google Scholar
  49. 49.
    Salamero J, Charreire J (1985) Syngeneic sensitisation of mouse lymphocytes on monolayers of thyroid epithelial cells (TEC) VII. Generation of thyroid specific cytotoxic effector cells. Cell Immunol 91:111–118Google Scholar
  50. 50.
    Sarvetnick N, Liggit D, Pitts SL, Hansen SE, Stewart TA (1988) Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of Class II MHC and interferon-gamma. Cell 52:773–782Google Scholar
  51. 51.
    Selby WS, Janossy G, Mason DY, Jewell DP (1983) Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol 53:614–618Google Scholar
  52. 52.
    Stastny P, Ball EJ, Khan MA, Olsen NJ, Pincus T, Gao X (1988) HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol [Suppl II] 27:132–138Google Scholar
  53. 53.
    Spencer J, Finn T, Isaacson PG (1986) Expression of HLA-DR antigens on epithelium associated with lymphoid tissue in human gastrointestinal tract. Gut 27:153–157Google Scholar
  54. 54.
    Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldmann M (1985) Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 61:265–273Google Scholar
  55. 55.
    Todd I, Lucas-Martin A, Abdul-Karim BAS, Hammond LJ, Bottazzo GF (1986a) HLA-D subregion expression by thyrocytes is associated with the occurrence of circulating thyroid autoantibodies. Annales d'Endocrinologie 47:20Google Scholar
  56. 56.
    Todd I, McNally JM, Hammond LJ, Pujol-Borrell R (1986b) TSH enhances expression by thyrocytes of interferon-gamma induced HLA-D/DR. In: Medeiros-Neto G, Gaitan E (eds) Frontiers in Thyroidology. Plenum Press, New York, pp 1551–1554Google Scholar
  57. 57.
    Todd I, Pujol-Borrel R, Abdul-Karim BAS, Hammond LJ, Feldmann M, Bottazzo GF (1987) HLA-D subregion expression by thyroid epithelium in autcimmune thyroid diseases and induced in vitro. Clin Exp Immunol 69:532–542Google Scholar
  58. 58.
    Todd JA, Acha-Orbea H, Bell JI, Chao N, Frorek Z, Jacob CO, McDermott M, Sinha AA, Timmerman L, Steinman L, McDevitt HO (1988) A molecular basis for MHC Class II-associated autoimmunity. Science 240:1003–1009Google Scholar
  59. 59.
    Weetman AP, Volkman DJ, Burman KD, Gerrard TL, Fauci AS (1985) The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocr Metab 61:817–824Google Scholar
  60. 60.
    Wenzel BE, Gutekunst R, Mansky T, Schultek T, Scriba PC (1986) Thyrotropin and IgG from patients with Graves' disease induce class-II antigen on human thyroid cells. In: Drexhage HA, Wiersinga WM (eds) The Thyroid and Autoimmunity. Excerpta Medica, Amsterdam, pp 141–144Google Scholar
  61. 61.
    Zinkernagel RM, Doherty RC (1974) Immunological surveillance against altered self-components by sensitized T lymphocytes in lymphocytic choriomeningitis. Nature 251:547–548Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • U. Deuß
    • 1
  • M. Buscema
    • 2
  • G. F. Bottazzo
    • 2
  • W. Winkelmann
    • 1
  1. 1.Medizinische Universitätsklinik II, Krankenhaus Köln-MerheimGermany
  2. 2.Department of ImmunologyUniversity College and Middlesex School of MedicineLondonUK

Personalised recommendations